Boehringer Ingelheim

For Healthcare Professionals

Logout

Boehringer Ingelheim

Boehringer Ingelheim

Boehringer Ingelheim

Therapeutic Area
Therapeutic Area

At Boehringer Ingelheim we are driven by the desire to serve mankind by improving human and animal health. As a successful, family owned company we plan in generations. We work together globally and with integrity. Our Focus articulates who we are and what we strive for, how we work and what we want to achieve.

Section Overview

Therapeutic Area

Section Overview

Cardiovascular

Metabolic

Inflammation

Respiratory
Products
Products

Boehringer Ingelheim is a research-driven group of companies dedicated to the discovery, development, manufacture and marketing of innovative health care products.

See all products

Products

See all products
Resources
Contact
Logout

Boehringer Ingelheim

Efficacy
Safety

Simple.
Every day.

Metabolic Linagliptin

Ask the Expert: Prof O'Brien on Broad Range of Patients

31/01/2023 | Document ID: PC-PH-104543

Simplicity

With CARMELINA®, linagliptin demonstrated a long-term cardiovascular safety profile in patients with T2D and showed no increase in risk of hospitalisation for heart failure

Limited to kidney video by Prof. Roger Chen

Ask the Expert: Prof O'Brien on Broad Range of Patients

RELATED CONTENT

03:35

Linagliptin (Trajenta): True convenience for a broad range of patients

Watch now Opens in new tab

Production Date: January 2023

Home
Metabolic
Linagliptin
Simplicity
Ask the Expert: Prof O'Brien on Broad Range of Patients

Sitemap

Therapeutic Area

Resources
- Videos
- Clinical studies

BI logo

Privacy
Terms of use
Sitemap
Contact

Copyright © 2025 Boehringer Ingelheim (Philippines), Inc. All rights reserved. Use of this Site is subject to the Terms of Use and Privacy Statement. Prepared June 2025